http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MX-9804706-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_58209a99602b20c360e8d2eb8b6bee97
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-70
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-70
filingDate 1998-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e8dbbc5ec8da16b4ef3ec463b4a10243
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6294f42412eb9b0e91d8374ab70e9a00
publicationDate 1998-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber MX-9804706-A
titleOfInvention ISOINDOLONE FUSED AS PROTEIN KINASE C INHIBITORS.
abstract Biologically active indole-free compounds are disclosed, referred to as fused isoindolones, which are represented by the general formula (I). The fused isoindolones can be obtained by complete chemical synthesis. Methods for manufacturing and using the fused isoindolones are disclosed.
priorityDate 1995-12-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID48311
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID36897
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP13678
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ4WVG0
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID32191
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID852169
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415870278
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID191109
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407208027
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID181244
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID798
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID43428
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ25378
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3878409

Total number of triples: 26.